Nichol Geoffrey Insider Trades

Insider Trading History

Track insider trading activity for Nichol Geoffrey. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Tempest Therapeutics
Tempest Therapeutics TPST
Director
Holding Value $1.6k 1,230 shares
Last Trade
Jan 27, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.62k 1,230 shares
$2.94
$1.30
Tempest Therapeutics
Tempest Therapeutics TPST
Director
Holding Value $20.8k 16,000 shares
Last Trade
Jun 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$48.5k 16,000 shares
$3.03
$1.30
Tempest Therapeutics
Tempest Therapeutics TPST
Director
Holding Value $10.7k 8,200 shares
Last Trade
Jun 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$151k 8,200 shares
$18.46
$1.30
Tempest Therapeutics
Tempest Therapeutics TPST
Director
Holding Value $4.55k 3,500 shares
Last Trade
Jun 17, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.28k 3,500 shares
$2.08
$1.30
Millendo Therapeutics
Millendo Therapeutics MLND
Director
Holding Value $3.71k 3,500 shares
Last Trade
Jun 17, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.71k 3,500 shares
$1.06
$1.06
Tempest Therapeutics
Tempest Therapeutics TPST
Director
Holding Value $8.63k 6,635 shares
Last Trade
Jul 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$73.4k 6,635 shares
$11.07
$1.30
Millendo Therapeutics
Millendo Therapeutics MLND
Director
Holding Value $7.03k 6,635 shares
Last Trade
Jul 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.03k 6,635 shares
$1.06
$1.06
Tempest Therapeutics
Tempest Therapeutics TPST
Holding Value $8.63k 6,635 shares
Last Trade
Jul 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$73.4k 6,635 shares
$11.07
$1.30
Millendo Therapeutics
Millendo Therapeutics MLND
Director
Holding Value $12.7k 12,000 shares
Last Trade
Jun 22, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$28.8k 12,000 shares
$2.40
$1.06
Tempest Therapeutics
Tempest Therapeutics TPST
Director
Holding Value $15.6k 12,000 shares
Last Trade
Jun 22, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$432k 12,000 shares
$36.00
$1.30
Millendo Therapeutics
Millendo Therapeutics MLND
Director
Holding Value $25.4k 24,000 shares
Last Trade
Dec 17, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$151k 24,000 shares
$6.29
$1.06
Tempest Therapeutics
Tempest Therapeutics TPST
Director
Holding Value $31.2k 24,000 shares
Last Trade
Dec 17, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.26M 24,000 shares
$94.35
$1.30
Sangamo Therapeutics
Sangamo Therapeutics SGMO
Executive Vice President, R&d
Holding Value $33.5k 159,676 shares
Last Trade
Dec 12, 2015 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$38.1k 4,384 shares
$8.68
$0.21
Sangamo Therapeutics
Sangamo Therapeutics SGMO
Executive Vice President, R&d
Holding Value $34.4k 164,060 shares
Last Trade
Dec 11, 2015 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$40.8k 4,697 shares
$8.68
$0.21
Sangamo Therapeutics
Sangamo Therapeutics SGMO
Executive Vice President, R&d
Holding Value $36.8k 175,646 shares
Last Trade
Dec 08, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$353k 37,500 shares
$9.41
$0.21
Sangamo Therapeutics
Sangamo Therapeutics SGMO
Executive Vice President, R&d
Holding Value $15.7k 75,000 shares
Last Trade
Dec 08, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$706k 75,000 shares
$9.41
$0.21
Sangamo Therapeutics
Sangamo Therapeutics SGMO
Executive Vice President, R&d
Holding Value $35.4k 168,757 shares
Last Trade
Dec 07, 2015 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$66.8k 6,889 shares
$9.69
$0.21
Sangamo Therapeutics
Sangamo Therapeutics SGMO
Executive Vice President, R&d
Holding Value $28.9k 138,146 shares
Last Trade
Dec 15, 2014 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$615k 41,743 shares
$14.74
$0.21
Sangamo Therapeutics
Sangamo Therapeutics SGMO
Executive Vice President, R&d
Holding Value $15.7k 75,000 shares
Last Trade
Dec 11, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.06M 75,000 shares
$14.07
$0.21
Sangamo Therapeutics
Sangamo Therapeutics SGMO
Executive Vice President, R&d
Holding Value $37.7k 179,889 shares
Last Trade
Dec 11, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$528k 37,500 shares
$14.07
$0.21

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up